Compare LFCR & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFCR | EMF |
|---|---|---|
| Founded | 1986 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.0M | 245.9M |
| IPO Year | N/A | N/A |
| Metric | LFCR | EMF |
|---|---|---|
| Price | $8.30 | $16.50 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 172.3K | 29.3K |
| Earning Date | 01-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $128,867,000.00 | N/A |
| Revenue This Year | $2.80 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.47 | N/A |
| 52 Week Low | $4.76 | $10.58 |
| 52 Week High | $8.85 | $12.67 |
| Indicator | LFCR | EMF |
|---|---|---|
| Relative Strength Index (RSI) | 59.43 | 39.97 |
| Support Level | $7.85 | $16.20 |
| Resistance Level | $8.77 | $16.62 |
| Average True Range (ATR) | 0.36 | 0.24 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 63.64 | 17.72 |
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
Templeton Emerging Markets Fund is a closed-end management investment company that seeks long-term capital appreciation by investing mainly in emerging country equity securities under normal market conditions. It invests across various sectors, including Pharmaceuticals, Beverages, Broadline Retail, Metals & Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, Insurance, Entertainment, and others.